Quantcast
Viewing all articles
Browse latest Browse all 4143

Bristol Myers CEO signals dealmaking will be a top priority in 2025

Is Bristol Myers Squibb ready to take on big dealmaking again? When CEO Chris Boerner took over in late 2023, Bristol Myers was in a difficult position. Its stock price {$BMY} was down more than ...

Viewing all articles
Browse latest Browse all 4143

Trending Articles